Suchergebnisse - (Subject:"Humans")

PubPharm (57.319)

1

Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker

enthalten in: The journal of gene medicine | 2024

von Dai, L. | Xiao, J. | Li, X. | +7

2

ARID1 and BRG1 Expression in Endometrial Cancer

enthalten in: In vivo (Athens, Greece) | 2024

von Kontomanolis, E. | Symeonidis, P. | Nikolettos, K. | +5

3

Identification and Quantification of Radiotherapy-related Protein Expression in Cancer Tissues Using the Qupath Software and Prediction of Treatment Response

enthalten in: In vivo (Athens, Greece) | 2024

von Hasegawa, T. | Someya, M. | Tsuchiya, T. | +13

4

Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma

enthalten in: In vivo (Athens, Greece) | 2024

von Hsu, H. | Lin, Y. | Hsing, M. | +3

5

VDR is a potential prognostic biomarker and positively correlated with immune infiltration : a comprehensive pan-cancer analysis with experimental verification

enthalten in: Bioscience reports | 2024

von Xia, X. | Xu, F. | Dai, D. | +9

6

Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) : A prospective biomarker prevalence study

enthalten in: Oral oncology | 2024

von Hong, R. | Yen, C. | Lien, M. | +5

7

The role of miR-155 in urologic malignancies

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2024

von Shen, M. | Chen, T. | Li, X. | +4

8

Comment on "Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) : A prospective biomarker prevalence study"

enthalten in: Oral oncology | 2024

von Aragão, H. | Monteiro, M. | Lopes, N. | +1

9

Comment on betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) : A prospective biomarker prevalence study

enthalten in: Oral oncology | 2024

von Sekar, D.

10

Immune effector dysfunction signatures predict outcomes in patients with colorectal cancer

enthalten in: International immunopharmacology | 2024

von Tang, H. | Wu, H. | Jian, Y. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[5732]